SAS-B approvals hit second highest on record as Tassie shows surprise growth by Steve Jones April 2, 2025April 2, 2025 Approvals through the Special Access Scheme (SAS) hit their second highest number on record last month […]
Althea blames medical sales decline on TGA ‘falling asleep at the wheel’ amid ‘crazy’ antics of competitors by Steve Jones March 21, 2025March 26, 2025
Pastilles drive Bioxyne to first-half profit after revenue climbs 171% by Steve Jones March 3, 2025March 3, 2025
Bioxyne sees sharp revenue growth as shares jump after strong quarter by Steve Jones October 17, 2024February 25, 2025
Montu named as customer behind ‘$28m’ gummy deal as Bioxyne resumes trading on ASX by Steve Jones September 18, 2024September 19, 2024
Avecho looks to Authorised Prescribers to find optimal dose for new fast-onset THC gummies by Steve Jones August 9, 2023August 21, 2023
